Galectin‐3 interacts with <scp>PD</scp>‐1 and counteracts the <scp>PD</scp>‐1 pathway‐driven regulation of T cell and osteoclast activity in Rheumatoid ArthritisKathrine Pedersen, Stinne Ravn Greisen, Morten Aagaard Nielsen et al.|Scandinavian Journal of Immunology|2022Cited by 11
Gal-3 blocks the binding between PD-1 and pembrolizumabStinne Ravn Greisen, Bent Deleuran, Nina Haunstrup Jensen et al.|Journal for ImmunoTherapy of Cancer|2024Cited by 11